CS
HOOK

Credit Suisse’s HOOKIPA Pharma HOOK Stock Holding History

Credit Suisse’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed – – 4139
2022
Q2 		$0 Buy
+1
New +$17 ﹤0.01% 4093

Other funds holding HOOK

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Credit Suisse's HOOK Position: Q3 2022 in Review

Credit Suisse sold out of HOOKIPA Pharma (HOOK) in Q3 2022, closing a stake of 1 share.

Credit Suisse first reported a position in HOOK in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 54 funds tracked by Wall St. Rank hold HOOK as of Q3 2022.

  • Credit Suisse reported no remaining HOOKIPA Pharma position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 1 HOOKIPA Pharma share in Q3 2022.
  • Credit Suisse first reported a position in HOOKIPA Pharma in Q2 2022 and held it in 1 quarter.
  • Credit Suisse's HOOKIPA Pharma position peaked at $0 in Q2 2022.
  • 54 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.